// App-Quantinova.ai

1424 : Predicting response to immune checkpoint therapy using an mutation burden threshold

Researchers

Presenter

  • Anshuman Panda

Principal Investigators

  • Anil Betigeri

  • Kalyanasundaram Subramanian

  • Kim Hirshfield

  • Lorna Rodriguez

  • Shridar Ganesan

  • Gyan Bhanot

Medical Centers

  • Department of Physics, Rutgers University, Piscataway, NJ

  • Strand Life Sciences, Bangalore, India

  • Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Locations

  • United States

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

Drug/Treatment

  • Pembrolizumab

  • Ipilimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved